Algorae Pharmaceuticals (ASX:1AI) has announced the appointment of experienced pharmaceutical executive Vishal Shah as its chief commercial officer.
The company said Mr Shah would lead its commercial strategy, supporting growth and expansion into complementary pharmaceutical market segments.
Mr Shah joins Algorae from HPS Pharmacies, part of EBOS, where he was responsible for procurement strategy, driving revenue growth, and expanding market reach.
Executive chairman David Hainsworth said, “We are thrilled to welcome Vishal to Algorae as our Chief Commercial Officer. His extensive experience in scaling up pharmaceutical businesses, forging strategic partnerships and driving revenue growth will be instrumental in propelling Algorae’s AI-driven innovation into market success.”
Before EBOS, Mr Shah held senior leadership roles at Baxter Healthcare, including associate director of Pharmaceuticals for Asia-Pacific and Head of Pharmaceuticals Australia and New Zealand.
Mr Shah said, “I am excited to join Algorae at such a pivotal time. Algorae’s AI-driven pharmaceutical strategy offers a competitive edge in transforming drug development and market penetration, and I look forward to working with the team to drive commercial success and expand our impact.”